- Infants (< 12 months at diagnosis) with MYCN amplified tumours are included. Children with this type of presentation and age represent the largest neuroblastoma subgroup. Their prognosis remains poor in most cases and our ability to predict the clinical course and the outcome of the individual patient is modest.